dr. mike snape video, page-21

Hi Wayne,

I had a very good feeling you did. :-)

You wrote;

Of course we will not know until next year yet an extraordinary window opened up through which we caught a glimpse of patients undergoing medication.

It sure did and agree, it was so incredibly exciting.

Worth re-highlighting....

What is true in Rett and Fragile X points towards a kind of universal drug for all "CNS conditions at the level of disease causation". So we are talking about Alzheimers disease, Parkinsons disease, autism, TBI and dementia. A universal drug in an unmet market.

The market also has a window of opportunity at these levels as I feel that window may be closed and gone for good very soon.

One of your best posts. Thank you.

Regards,
Tony